RODERICK WONG - 22 Jun 2023 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
Director, 10%+ Owner
Signature
/s/ Martin Wilson, as attorney-in-fact
Issuer symbol
RCKT
Transactions as of
22 Jun 2023
Net transactions value
+$50,009
Form type
4
Filing time
26 Jun 2023, 19:48:02 UTC
Previous filing
26 Jan 2023
Next filing
20 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Stock Option (Right to Buy) Award $0 +25,850 $0.000000 25,850 22 Jun 2023 Common Stock 25,850 $21.56 Direct F1
transaction RCKT Stock Option (Right to Buy) Award $50,009 +3,590 $13.93 3,590 22 Jun 2023 Common Stock 3,590 $21.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents a right to purchase a total of 25,850 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024.
F2 This option represents a right to purchase a total of 3,590 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 22, 2024. This option was issued to the Reporting Person in lieu of director retainer fees of $50,000.